Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Avoiding salicylates improved skin issues and stabilized hair loss in a woman with frontal fibrosing alopecia.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

FFA in young women is often missed, and no single treatment works best.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Early diagnosis and quick treatment improve life quality for FFA patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.